Tilray Brands, Inc. (TLRY) stock
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3086% below fair value
$2.43−0.06 (-2.41%)
Close on Nov 13, 2026Market cap $359.12MP/E –Yield –
Tilray Brands ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Tilray Brands's ebitda for the twelve months ending Aug 31, 2022 was -$433.77M. For fiscal 2022 it was -$455.81M. The highest annual figure on record is -$5.10M in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | May 31, 2022 | -$455.81M | – |
| FY2019 | Dec 31, 2019 | -$288.29M | – |
| FY2018 | Dec 31, 2018 | -$54.28M | – |
| FY2017 | Dec 31, 2017 | -$5.65M | – |
| FY2016 | Dec 31, 2016 | -$5.10M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $12.89M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$426.66M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $6.51M | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$26.51M | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$30.04M | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$211.24M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$20.59M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$30.57M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$25.67M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$21.90M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$19.48M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$10.71M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$3.26M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | -$2.16M | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -$1.74M | – |
See a number that looks wrong?